XML 22 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:      
Net loss $ (49,011) $ (75,118) $ (128,391)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation 93,554 98,777 114,312
Allowance for doubtful accounts, net of recoveries 271 53 156
Write-off of obsolete inventory 0 0 101
Gain on dispositions of property and equipment, net (3,121) (3,608) (1,892)
Stock-based compensation expense 4,444 4,349 3,944
Phantom stock compensation expense 46 1,609 1,971
Amortization of debt issuance costs and discount 2,900 1,548 1,776
Loss on extinguishment of debt 0 1,476 299
Impairment 4,422 1,902 12,815
Deferred income taxes 538 (5,030) (11,608)
Change in other noncurrent assets 565 (1) 662
Change in other noncurrent liabilities (426) 385 (1,493)
Changes in current assets and liabilities:      
Receivables (8,644) (49,750) 16,341
Inventory (4,841) (4,397) (630)
Prepaid expenses and other current assets (1,139) 744 310
Accounts payable (1,272) 12,409 1,969
Deferred revenues 420 (348) (3,985)
Accrued expenses 950 9,183 (1,526)
Net cash provided by (used in) operating activities 39,656 (5,817) 5,131
Cash flows from investing activities:      
Purchases of property and equipment (67,148) (63,277) (32,381)
Proceeds from sale of property and equipment 5,864 12,569 7,577
Proceeds from insurance recoveries 1,082 3,344 37
Net cash used in investing activities (60,202) (47,364) (24,767)
Cash flows from financing activities:      
Debt repayments 0 (120,000) (71,000)
Proceeds from issuance of debt 0 245,500 22,000
Debt issuance costs 0 (6,332) (819)
Proceeds from exercise of options 11 0 183
Proceeds from issuance of common stock, net of offering costs of $4,001 0 0 65,430
Net cash provided by (used in) financing activities (538) 118,635 15,670
Net increase (decrease) in cash, cash equivalents and restricted cash (21,084) 65,454 (3,966)
Beginning cash, cash equivalents, and restricted cash 75,648 10,194 14,160
Ending cash, cash equivalents, and restricted cash 54,564 75,648 10,194
Supplementary disclosure:      
Interest paid 36,624 25,082 24,516
Change in capital expenditure accruals 5,706 (1,830) 175
Income tax paid 3,556 1,431 671
Purchase of treasury stock $ (549) $ (533) $ (124)